At FDA's request, Type D Meeting expected in March 2026 to review Comparative Oncology biomarker data from patients treated in OST-HER2 Phase 2b human clinical trial and OST-HER2 trial in spontaneous ...

New eTMF module integrates with Enlighten Clinical Solutions’ platform to support inspection-ready clinical trial documentation and execution. ATLANTA, GA, UNITED ...

EHR vendors says Claude synthesizes complex, longitudinal patient data — including problem lists, medications, visit notes, labs, and vitals — into concise summaries In an August 2025 interview, Kyna ...